135 related articles for article (PubMed ID: 36179791)
1. Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists.
Irwin S; Karr C; Furman C; Tsai J; Gee P; Banka D; Wibowo AS; Dementiev AA; O'Shea M; Yang J; Lowe J; Mitchell L; Ruppel S; Fekkes P; Zhu P; Korpal M; Larsen NA
J Biol Chem; 2022 Nov; 298(11):102539. PubMed ID: 36179791
[TBL] [Abstract][Full Text] [Related]
2. PPARγ Corepression Involves Alternate Ligand Conformation and Inflation of H12 Ensembles.
Frkic RL; Pederick JL; Horsfall AJ; Jovcevski B; Crame EE; Kowalczyk W; Pukala TL; Chang MR; Zheng J; Blayo AL; Abell AD; Kamenecka TM; Harbort JS; Harmer JR; Griffin PR; Bruning JB
ACS Chem Biol; 2023 May; 18(5):1115-1123. PubMed ID: 37146157
[TBL] [Abstract][Full Text] [Related]
3. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
[TBL] [Abstract][Full Text] [Related]
4. Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.
Miyamae Y
Biol Pharm Bull; 2021; 44(9):1185-1195. PubMed ID: 34471046
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists
Orsi DL; Pook E; Bräuer N; Friberg A; Lienau P; Lemke CT; Stellfeld T; Brüggemeier U; Pütter V; Meyer H; Baco M; Tang S; Cherniack AD; Westlake L; Bender SA; Kocak M; Strathdee CA; Meyerson M; Eis K; Goldstein JT
J Med Chem; 2022 Nov; 65(21):14843-14863. PubMed ID: 36270630
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW
Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850
[TBL] [Abstract][Full Text] [Related]
7. A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.
Brust R; Shang J; Fuhrmann J; Mosure SA; Bass J; Cano A; Heidari Z; Chrisman IM; Nemetchek MD; Blayo AL; Griffin PR; Kamenecka TM; Hughes TS; Kojetin DJ
Nat Commun; 2018 Nov; 9(1):4687. PubMed ID: 30409975
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.
Waku T; Shiraki T; Oyama T; Maebara K; Nakamori R; Morikawa K
EMBO J; 2010 Oct; 29(19):3395-407. PubMed ID: 20717101
[TBL] [Abstract][Full Text] [Related]
9. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
[TBL] [Abstract][Full Text] [Related]
10. PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix.
Frkic RL; Marshall AC; Blayo AL; Pukala TL; Kamenecka TM; Griffin PR; Bruning JB
iScience; 2018 Feb; 5():69-79. PubMed ID: 30123887
[TBL] [Abstract][Full Text] [Related]
11. Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.
Zorrilla S; Garzón B; Pérez-Sala D
Anal Biochem; 2010 Apr; 399(1):84-92. PubMed ID: 20025845
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.
Mansure JJ; Nassim R; Kassouf W
Cancer Biol Ther; 2009 Apr; 8(7):6-15. PubMed ID: 19417560
[TBL] [Abstract][Full Text] [Related]
14. Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist.
Miyachi H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835351
[TBL] [Abstract][Full Text] [Related]
15. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.
Tsukahara T; Tsukahara R; Yasuda S; Makarova N; Valentine WJ; Allison P; Yuan H; Baker DL; Li Z; Bittman R; Parrill A; Tigyi G
J Biol Chem; 2006 Feb; 281(6):3398-407. PubMed ID: 16321982
[TBL] [Abstract][Full Text] [Related]
16. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
17. Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists.
Fratev F; Tsakovska I; Al Sharif M; Mihaylova E; Pajeva I
Int J Mol Sci; 2015 Jul; 16(7):15405-24. PubMed ID: 26184155
[TBL] [Abstract][Full Text] [Related]
18. [Design and Synthesis of Peroxisome Proliferator-activated Receptor (PPAR) Gamma Antagonists Based on the Principle of Operation of Nuclear Receptor I].
Ohashi M; Miyachi H
Yakugaku Zasshi; 2017; 137(8):957-967. PubMed ID: 28768949
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma (PPARγ) has multiple binding points that accommodate ligands in various conformations: Structurally similar PPARγ partial agonists bind to PPARγ LBD in different conformations.
Ohashi M; Gamo K; Oyama T; Miyachi H
Bioorg Med Chem Lett; 2015 Jul; 25(14):2758-62. PubMed ID: 26025876
[TBL] [Abstract][Full Text] [Related]
20. A molecular switch regulating transcriptional repression and activation of PPARγ.
Shang J; Mosure SA; Zheng J; Brust R; Bass J; Nichols A; Solt LA; Griffin PR; Kojetin DJ
Nat Commun; 2020 Feb; 11(1):956. PubMed ID: 32075969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
